- Appointment of Valérie Brissart as SVP Diagnostic Imaging
- Appointment of Jean-François Blanc as SVP Interventional Imaging
- Appointment of Gitte Hesselholt as Chief Commercial Officer Americas & EMEA
- Appointment of Mathieu Elie as Chief Commercial Officer Asia-Pacific
Villepinte (France), September 2, 2020 - 18:00 CEST - Guerbet (GBT), a global leader in medical imaging, is strengthening its Executive Committee with four new posts for its Diagnostic Imaging and Interventional Imaging franchises and its Asia-Pacific, Americas and EMEA regions.
This shift will accelerate Guerbet’s transformation and help realize its strategic ambitions for its three Diagnostic Imaging, Interventional Imaging and Digital Solutions franchises in its various international markets.
“This new organization will allow us to respond more rapidly to realties in the field and take us closer to our customers and teams. We will be able to execute our strategy and transform Guerbet more rapidly by involving all our business lines, with a more diverse executive committee,” said David Hale, CEO of Guerbet.
Valérie Brissart has joined the Executive Committee as SVP Diagnostic Imaging. She will oversee marketing in the CT and Cath Lab, MRI, Injection Systems & Services segments. Having spent 18 years at GE Healthcare in various marketing positions, including as Europe Marketing Director for CT and Nuclear Medicine, Valérie joined Guerbet in October 2018 as Global Marketing Director for CT and Cath Lab Imaging Solutions.
Jean-François Blanc has been appointed to the newly created position of SVP Interventional Imaging. He will head growth acceleration in this segment. Jean-François joined Guerbet in May 2015 as Senior Vice President of Technical Operations. Before working for Guerbet, Jean-François held various management positions at Becton-Dickinson and Medtronic in the medical device industry.
Gitte Hesselholt joined Guerbet on September 1 as Chief Commercial Officer Americas & EMEA. Gitte has extensive experience in driving business transformation and change management in the healthcare and consumer goods industries. Prior to joining Guerbet, Gitte was a partner at the Boston Consulting Group, having previously held management positions at Mölnlycke Health Care, Coloplast, Carlsberg and McKinsey & Co.
Mathieu Elie has joined the Executive Committee as Chief Commercial Officer Asia-Pacific. He will oversee the roll-out of the Go-Direct initiatives in China and India. Mathieu joined Guerbet in 2007 as Financial and Administrative Director of Guerbet in Korea, then took over at the head of business operations in Korea, Asia-Pacific and Latin America before becoming Vice President of the APAC region in 2015.
Guerbet is a leader in medical imaging worldwide, offering a wide range of pharmaceutical products, medical devices, digital and AI solutions for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients. A pioneer since more than 90 years in the field of contrast media with over 2,800 people globally, Guerbet is continuously innovating with 9% of revenue dedicated to Research & Development and four centers in France, Israel and the United States. Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €817 million in revenue in 2019. For more information about Guerbet, please visit www.guerbet.com.
+33 (0)6 64 18 99 59 / email@example.com